Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma.
Transl Oncol., Aug;5(4):247-51 (2012)
Nonrecommended breast and colorectal cancer screening for young women: a vignette-based survey.
Am J Prev Med., Sep;43(3):231-9 (2012)
Ovarian cancer: screening and early detection.
Obstet. Gynecol. Clin. North Am., Jun;39(2):183-94 (2012)
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
J. Clin. Oncol., Jun;30(17):2039-45 (2012)
Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
Int. J. Gynecol. Cancer., May;22(4):546-52 (2012)
Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations?
Ann. Intern. Med., Feb;156(3):182-94 (2012)
Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability.
Gynecol. Oncol., Feb;124(2):230-5 (2012)
Involvement in decision-making about treatment and ovarian cancer survivor quality of life.
Gynecol. Oncol., Mar;124(3):465-70 (2012)
Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer.
Gynecol. Oncol., Dec;123(3):461-6 (2011)
Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass.
Obstet Gynecol., Oct;118(4):854-62 (2011)
Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly.
Obstet Gynecol., Sep;118(3):537-47 (2011)
Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study.
Cancer., Aug;117(16):3731-40 (2011)
Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Cancer., Dec;117(23):5334-43 (2011)
Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
Am. J. Obstet. Gynecol., Jun;204(6):466-78 (2011)
Trends in treatment of advanced epithelial ovarian cancer in the Medicare population.
Gynecol. Oncol., Jul;122(1):100-6 (2011)
Patterns of spread and recurrence of sex cord-stromal tumors of the ovary.
Gynecol. Oncol., Aug;122(2):242-5 (2011)
How are symptoms of ovarian cancer managed? A study of primary care physicians.
Cancer., Oct;117(19):4414-23 (2011)
Pelvic exenteration in the age of modern chemoradiation.
Gynecol. Oncol., Apr;121(1):131-4 (2011)
Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.
Neoplasia., Dec;12(12):993-1002 (2010)
FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.
Gynecol. Oncol., Feb;120(2):296-9 (2011)